Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Novavax Inc Extends Acceptance Period for Shares in Isconova AB; Plans to Apply for Delisting of Isconova-Direkt


Wednesday, 31 Jul 2013 02:17am EDT 

Direkt reported that Novavax Inc has acquired approximately 97.4% of shares in Isconova AB, and owns 100% of warrants issued by the company. Novavax has decided to extend the acceptance period until August 20, 2013, and communicated that the Company will apply for delisting Isconova's shares from First North. 

Company Quote

5.81
0.18 +3.20%
24 Dec 2014